Subscribe


PD breaking news – Strides Arcolab buys Aspen business in Australia

Operation to trade under Arrow Pharmaceuticals brand. 

Indian pharmaceutical giant Strides Arcolab has announced an agreement with Aspen Pharmacare Holdings Limited, to acquire the Aspen generic pharmaceutical business in Australia.

The company said the business and assets being acquired have a current prescription market share which will rank Strides as one of the top three generic pharmaceutical suppliers in Australia, and among the top ten pharmaceutical companies in the Australian pharma market, the company said.

To operate under the Arrow Pharmaceuticals brand, the business will sell about 140 generic prescription drugs and an extensive range of non-prescription pharmacy products, giving Strides “one of the largest pharmaceutical portfoliios in the Australian market”.

Strides previously operated in Australia under the Ascent Pharmahealth brand, which was sold to Actavis in 2012. The new Arrow Pharmaceuticals business will be led by Dennis Bastas, the previous founder and ceo of Ascent Pharmahealth.

Aspen expanded in the Australian market in 2010 when it purchased the generics business of Sigma Pharmaceuticals for $900 million.

Strides said today’s purchase from Aspen is valued at approximately $380 million. 

More details in Monday’s issue of Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 22 May 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

23 Jan

Guild Update 23 Jan 18 - WITH just over a week to go ...


23 Jan

Dispensary Corner 23 Jan 18 - KEEPING kids who suffer from conditions such ...


23 Jan

NZSMI blasts NZ codeine upschedule - ...


23 Jan

Pharmacy BP clinics - THE role community pharmacies can play in ...


23 Jan

Zantac discount deal - ASPEN Australia is promoting a special "double ...


23 Jan

Not-so-smart thief - A woman has been sentenced in the ...


23 Jan

February epidemic asthma surge - THE National Asthma Council Australia is urging ...


23 Jan

New GSK APAC chief - GSK Consumer Healthcare has appointed Filippo Lanzi ...


23 Jan

Pharmacists and AMR - PHARMACISTS are an "underutilised resource for Antimicrobial ...


23 Jan

Adherence Perx - SYDNEY start-up Perx Health, with the support ...


23 Jan

FDA recall guidance - THE U.S. Food and Drug Administration (FDA) ...


23 Jan

TGA extends tender - THE TGA has extended the lodgement date ...


23 Jan

CMA blasts ‘fringe’ groups - COMPLEMENTARY Medicines Australia (CMA) has criticised Friends ...


23 Jan

Dose Innovations administration - EXTERNAL administrators have been appointed to Brisbane-based ...


22 Jan

Weekly Comment 22 Jan 18 - WELCOME to PD's weekly comment feature. This ...


22 Jan

Dispensary Corner 22 Jan 18 - MEDICINAL marijuana is the subject of several ...


22 Jan

FDA pings Delta Labs - THE US Food and Drug Administration (FDA) ...


22 Jan

S3 ad clarification - THE Therapeutic Goods Administration has stressed that ...


22 Jan

Opioid consultation - OPTIONS for a regulatory response to opioid ...


22 Jan

Metformin recall - APOTEX is recallilng one patch of APO-Metformin ...



Show Pharmacy Daily items by month: